Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

(2013) Tamara Kusay Jabbar et al.   PLoS One

African horse sickness in naturally infected, immunised horses

(2012) C. T. WEYER et al.   EQUINE VETERINARY JOURNAL

Structural Insight into African Horsesickness Virus Infection

(2012) V. Manole et al.   JOURNAL OF VIROLOGY

An Equine Herpesvirus Type 1 (EHV-1) Expressing VP2 and VP5 of Serotype 8 Bluetongue Virus (BTV-8) Induces Protection in a Murine Infection Model

(2012) Guanggang Ma et al.   PLoS One

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus

(2012) Eva Calvo-Pinilla et al.   PLoS One

Virus-specific CD8+ T-cells detected in PBMC from horses vaccinated against African horse sickness virus

(2012) Alri Pretorius et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses

(2012) H. El Garch et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

(2011) Javier Castillo-Olivares et al.   PLoS One

Detection of a Fourth Orbivirus Non-Structural Protein

(2011) Mourad Belhouchet et al.   PLoS One

Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen

(2011) Valentina Franceschi et al.   VACCINE

Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient mice

(2010) E. Calvo-Pinilla et al.   JOURNAL OF GENERAL VIROLOGY

In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6

(2010) Beate F. von Teichman et al.   VACCINE

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)

(2009) Rachael Chiam et al.   PLoS One

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection

(2009) Eva Calvo-Pinilla et al.   VACCINE

Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus

(2009) Alan J. Guthrie et al.   VACCINE

Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model

(2008) Jennifer L. Kyle et al.   VIROLOGY